Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3771929 | 0.87 | HTR5A (0.33) | HTR5ATDP1 | |
| SCHEMBL9692553 | 0.84 | TAAR1 (0.38) | HTR5A | |
| SCHEMBL8938192 | 0.84 | HTR5A (0.32) | HTR5A | |
| SCHEMBL9691832 | 0.81 | HTR5A (0.33) | HTR5A | |
| SCHEMBL10402771 | 0.81 | HTR5A (0.33) | HTR5A | |
| SCHEMBL9008384 | 0.81 | PNMT (0.33) | HTR5A | |
| SCHEMBL30349477 | 0.80 | ALDH1A1 (0.40) | HTR5A | |
| SCHEMBL30349330 | 0.80 | ALDH1A1 (0.40) | HTR5A | |
| SCHEMBL23662479 | 0.79 | KIF11 (0.38) | — | |
| SCHEMBL8378247 | 0.78 | TDP1 (0.34) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5534626-A | SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST INTERMEDIATES | PFIZER INC. (US) | 1996-07-09 | — | — | US | disclosed |
| EP-0510003-B1 | PIPERIDINE AND PYRROLIDINE DERIVATIVES | PFIZER LTD (GB) | 1995-09-27 | — | — | EP | disclosed |
| US-5410046-A | Selective muscarinic receptor antagonists | PFIZER INC. (US) | 1995-04-25 | — | — | US | disclosed |
| US-5344835-A | Muscarinic receptor antagonists, smooth muscle relaxants, irritable bowel syndrome | PFIZER INC. (US) | 1994-09-06 | — | — | US | disclosed |
| US-5302595-A | Muscarinic receptor antagonists | PFIZER INC. (US) | 1994-04-12 | — | — | US | disclosed |
| US-5231104-A | Anticholinergic | PFIZER INC. (US) | 1993-07-27 | — | — | US | disclosed |
| US-5219871-A | MUSCARINIC RECEPTOR ANTAGONISTS | PFIZER INC. (US) | 1993-06-15 | — | — | US | disclosed |
| US-5192765-A | Smooth muscle, bowel, bladder and airway diseases | PFIZER INC. (US) | 1993-03-09 | — | — | US | disclosed |
| EP-0350309-B1 | PIPERIDINE DERIVATIVES | Pfizer Limited (GB) | 1992-11-11 | — | — | EP | disclosed |
| EP-0510003-A1 | PIPERIDINE AND PYRROLIDINE DERIVATIVES. | PFIZER LTD (GB) | 1992-10-28 | — | — | EP | disclosed |
| EP-0438533-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | Pfizer Limited (GB) | 1991-07-31 | — | — | EP | disclosed |
| WO-1991010650-A1 | PIPERIDINE AND PYRROLIDINE DERIVATIVES | PFIZER LIMITED (GB) | 1991-07-25 | — | — | WO | disclosed |
| EP-0252005-B1 | HYDROGENATED 1-BENZOOXACYCLOALKYL-PYRIDINE CARBOXYLIC-ACID COMPOUNDS | CIBA-GEIGY AG (CH) | 1991-07-10 | — | — | EP | disclosed |
| EP-0364123-B1 | MUSCARINIC RECEPTOR ANTAGONISTS | Pfizer Limited (GB) | 1991-06-12 | — | — | EP | disclosed |
| US-4957928-A | NOOTROPIC AGENTS, COGNITION ACTIVATORS | CIBA-GEIGY CORPORATION (US) | 1990-09-18 | — | — | US | disclosed |
| WO-1990004583-A1 | MUSCARINIC RECEPTOR ANTAGONISTS | PFIZER LIMITED (GB) | 1990-05-03 | — | — | WO | disclosed |
| EP-0365093-A1 | Muscarinic receptor antagonists | PFIZER INC. (US) | 1990-04-25 | — | — | EP | disclosed |
| EP-0364123-A1 | Muscarinic receptor antagonists | Pfizer Limited (GB) | 1990-04-18 | — | — | EP | disclosed |
| EP-0350309-A1 | Piperidine derivatives | Pfizer Limited (GB) | 1990-01-10 | — | — | EP | disclosed |
| EP-0252005-A1 | Hydrogenated 1-benzooxacycloalkyl-pyridine carboxylic-acid compounds | CIBA-GEIGY AG (CH) | 1988-01-07 | — | — | EP | disclosed |